Related Experiment Videos
Immune status of HIV and HCV negative haemophiliacs treated with intermediate-purity factor VIII concentrates
Lancet (London, England)
|October 9, 1993
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The use of a novel burn dressing out of bacterial nanocellulose compared to the French standard of care in paediatric 2nd degree burns - A retrospective analysis.
Burns : journal of the International Society for Burn Injuries·2021
Continuous pH monitoring in wounds using a composite indicator dressing - A feasibility study.
Burns : journal of the International Society for Burn Injuries·2019
First report on the safety and efficacy of an extended half-life glycoPEGylated recombinant FVIII for major surgery in severe haemophilia A.
Haemophilia : the official journal of the World Federation of Hemophilia·2017
Immune tolerance therapy in paediatric haemophiliacs with factor VIII inhibitors: 14 years follow-up.
Haemophilia : the official journal of the World Federation of Hemophilia·2016
Changes in the amino acid sequence of the recombinant human factor VIIa analog, vatreptacog alfa, are associated with clinical immunogenicity.
Journal of thrombosis and haemostasis : JTH·2015
Governing the digital determinants of health for children and young people: a global public health imperative.
Lancet (London, England)·2026
The digital determinants of health: a new era for global public health.
Lancet (London, England)·2026
A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.
Lancet (London, England)·2026